IO Biotech Company
IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Copenhagen, Hovedstaden, Denmark
Founded Date:
2014-12-23
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
16
Total Funding:
159883430
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-10-07
Last Funding Type:
Series C
Register and Claim Ownership